As medical practitioners, understanding Parkinson's disease (PD) is crucial for effective patient care.
PD is a neurodegenerative disorder characterized by dopaminergic neuron loss in the substantia nigra, leading to motor and non-motor symptoms.
Patients often present with bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms include cognitive impairment, mood disorders, and autonomic dysfunction.
Treatment focuses on symptom management, primarily through dopaminergic therapies. Non-pharmacological interventions and deep brain stimulation are also beneficial.
Understanding PD's complexities aids in providing comprehensive, patient-centered care.
1.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
2.
New drug combination shows particularly good results in patients with HPV-negative head and neck cancer
3.
Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL
4.
A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll
5.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
1.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
2.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
3.
Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment
4.
Quality of Life Optimization in Long-Term Cancer Survivorship
5.
Molecular Matching for Individualized Blood-Disorder Therapy
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
How Nutrition Can Support Patients During Cancer Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation